 Jayne Martin Carli
Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammary Glands, Human | 2 | 2021 | 67 | 1.300 |
Why?
| | Lactation | 2 | 2021 | 192 | 1.210 |
Why?
| | Milk, Human | 2 | 2021 | 172 | 1.150 |
Why?
| | Adipogenesis | 2 | 2018 | 57 | 0.810 |
Why?
| | Adipocytes | 2 | 2018 | 223 | 0.730 |
Why?
| | Single-Cell Analysis | 2 | 2021 | 359 | 0.660 |
Why?
| | Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 2 | 2018 | 27 | 0.590 |
Why?
| | Computational Biology | 2 | 2021 | 681 | 0.580 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 442 | 0.570 |
Why?
| | Epithelial Cells | 2 | 2021 | 1126 | 0.540 |
Why?
| | Adenosine | 1 | 2018 | 255 | 0.490 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 321 | 0.480 |
Why?
| | Lipid Metabolism | 1 | 2018 | 528 | 0.430 |
Why?
| | Adiposity | 3 | 2020 | 543 | 0.380 |
Why?
| | Interleukin-2 | 2 | 2011 | 437 | 0.370 |
Why?
| | CD56 Antigen | 2 | 2013 | 35 | 0.340 |
Why?
| | DNA | 1 | 2018 | 1464 | 0.340 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2011 | 80 | 0.340 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2018 | 428 | 0.300 |
Why?
| | Leptin | 3 | 2020 | 245 | 0.270 |
Why?
| | Killer Cells, Natural | 2 | 2013 | 469 | 0.270 |
Why?
| | Prader-Willi Syndrome | 2 | 2017 | 31 | 0.260 |
Why?
| | T-Lymphocytes | 2 | 2011 | 1982 | 0.220 |
Why?
| | Neurons | 3 | 2017 | 1642 | 0.190 |
Why?
| | Immunoglobulin G | 3 | 2013 | 893 | 0.190 |
Why?
| | Flow Cytometry | 2 | 2020 | 1173 | 0.180 |
Why?
| | RNA, Small Nucleolar | 2 | 2017 | 8 | 0.170 |
Why?
| | Gene Knockdown Techniques | 2 | 2018 | 336 | 0.160 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2018 | 4 | 0.140 |
Why?
| | 3T3-L1 Cells | 1 | 2018 | 36 | 0.140 |
Why?
| | Immunosuppressive Agents | 3 | 2013 | 847 | 0.140 |
Why?
| | Postpartum Period | 1 | 2020 | 365 | 0.130 |
Why?
| | Hypothalamus | 2 | 2015 | 153 | 0.130 |
Why?
| | Proprotein Convertase 1 | 1 | 2016 | 4 | 0.130 |
Why?
| | Extracellular Matrix Proteins | 1 | 2018 | 159 | 0.130 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2013 | 988 | 0.130 |
Why?
| | Growth Hormone-Releasing Hormone | 1 | 2016 | 19 | 0.130 |
Why?
| | Proinsulin | 1 | 2016 | 51 | 0.120 |
Why?
| | Stem Cells | 1 | 2020 | 627 | 0.120 |
Why?
| | Protein Precursors | 1 | 2016 | 137 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2018 | 437 | 0.120 |
Why?
| | Induced Pluripotent Stem Cells | 2 | 2016 | 276 | 0.110 |
Why?
| | Neoplasm Proteins | 1 | 2018 | 444 | 0.110 |
Why?
| | Research Design | 1 | 2021 | 1137 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1721 | 0.100 |
Why?
| | Phosphorylation | 1 | 2018 | 1733 | 0.100 |
Why?
| | Antibodies, Monoclonal | 2 | 2011 | 1524 | 0.100 |
Why?
| | Vasculitis, Central Nervous System | 1 | 2013 | 16 | 0.100 |
Why?
| | DNA Methylation | 1 | 2018 | 683 | 0.100 |
Why?
| | Cilia | 1 | 2014 | 173 | 0.090 |
Why?
| | Mice | 6 | 2018 | 18365 | 0.090 |
Why?
| | Signal Transduction | 3 | 2018 | 5233 | 0.090 |
Why?
| | Polymorphism, Genetic | 1 | 2014 | 612 | 0.090 |
Why?
| | Islets of Langerhans | 1 | 2017 | 833 | 0.080 |
Why?
| | Lewis X Antigen | 1 | 2010 | 5 | 0.080 |
Why?
| | Interleukin-7 Receptor alpha Subunit | 1 | 2010 | 11 | 0.080 |
Why?
| | Lipolysis | 1 | 2010 | 46 | 0.080 |
Why?
| | Adipose Tissue | 2 | 2016 | 653 | 0.080 |
Why?
| | K562 Cells | 1 | 2010 | 93 | 0.080 |
Why?
| | Interleukin-7 | 1 | 2010 | 65 | 0.080 |
Why?
| | Multiple Sclerosis | 2 | 2013 | 484 | 0.080 |
Why?
| | Antigen Presentation | 1 | 2011 | 205 | 0.080 |
Why?
| | Cells, Cultured | 3 | 2015 | 4155 | 0.080 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2010 | 223 | 0.080 |
Why?
| | Forkhead Transcription Factors | 1 | 2010 | 202 | 0.070 |
Why?
| | Genome-Wide Association Study | 1 | 2016 | 1407 | 0.070 |
Why?
| | Animals | 7 | 2018 | 38109 | 0.070 |
Why?
| | Proteins | 1 | 2014 | 1022 | 0.070 |
Why?
| | Mice, Inbred C57BL | 4 | 2018 | 5997 | 0.070 |
Why?
| | 3T3 Cells | 1 | 2018 | 156 | 0.070 |
Why?
| | Pregnancy | 1 | 2020 | 7191 | 0.070 |
Why?
| | Dendritic Cells | 1 | 2011 | 499 | 0.070 |
Why?
| | Leukocytes, Mononuclear | 1 | 2010 | 573 | 0.060 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2010 | 389 | 0.060 |
Why?
| | Female | 6 | 2021 | 78376 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2015 | 2050 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2016 | 2609 | 0.060 |
Why?
| | Diet, High-Fat | 1 | 2018 | 261 | 0.060 |
Why?
| | Humans | 9 | 2021 | 144957 | 0.060 |
Why?
| | Obesity | 2 | 2016 | 3082 | 0.050 |
Why?
| | Weight Loss | 1 | 2010 | 837 | 0.050 |
Why?
| | Cell Line | 1 | 2010 | 2882 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2010 | 2499 | 0.050 |
Why?
| | Transcription Factors | 2 | 2017 | 1742 | 0.030 |
Why?
| | Prosencephalon | 1 | 2017 | 53 | 0.030 |
Why?
| | Protein Conformation | 1 | 2020 | 946 | 0.030 |
Why?
| | Sequence Deletion | 1 | 2017 | 193 | 0.030 |
Why?
| | Adult | 1 | 2020 | 40506 | 0.030 |
Why?
| | Multigene Family | 1 | 2017 | 204 | 0.030 |
Why?
| | Hyperphagia | 1 | 2016 | 38 | 0.030 |
Why?
| | Hypogonadism | 1 | 2016 | 90 | 0.030 |
Why?
| | Tissue Culture Techniques | 1 | 2016 | 83 | 0.030 |
Why?
| | Cerebellum | 1 | 2017 | 223 | 0.030 |
Why?
| | Genotype | 1 | 2020 | 1835 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 906 | 0.030 |
Why?
| | Genetic Variation | 1 | 2020 | 984 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1619 | 0.030 |
Why?
| | Pro-Opiomelanocortin | 1 | 2015 | 20 | 0.030 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2015 | 16 | 0.030 |
Why?
| | Antigens, Differentiation | 1 | 2015 | 77 | 0.030 |
Why?
| | Receptors, Leptin | 1 | 2014 | 25 | 0.030 |
Why?
| | Embryonic Stem Cells | 1 | 2015 | 130 | 0.030 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2015 | 148 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2017 | 524 | 0.030 |
Why?
| | Hedgehog Proteins | 1 | 2015 | 197 | 0.020 |
Why?
| | Introns | 1 | 2014 | 254 | 0.020 |
Why?
| | Methylprednisolone | 1 | 2013 | 64 | 0.020 |
Why?
| | STAT3 Transcription Factor | 1 | 2014 | 207 | 0.020 |
Why?
| | Cyclophosphamide | 1 | 2013 | 266 | 0.020 |
Why?
| | Eating | 1 | 2014 | 392 | 0.020 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2011 | 24 | 0.020 |
Why?
| | Transplantation Tolerance | 1 | 2011 | 37 | 0.020 |
Why?
| | Disability Evaluation | 1 | 2013 | 310 | 0.020 |
Why?
| | Models, Immunological | 1 | 2011 | 100 | 0.020 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2010 | 23 | 0.020 |
Why?
| | Male | 5 | 2017 | 72406 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 851 | 0.020 |
Why?
| | Acyltransferases | 1 | 2010 | 78 | 0.020 |
Why?
| | Weight Gain | 1 | 2014 | 559 | 0.020 |
Why?
| | Lipase | 1 | 2010 | 75 | 0.020 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2010 | 158 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2015 | 749 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 3125 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2011 | 1048 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3164 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2013 | 475 | 0.020 |
Why?
| | Fibroblasts | 1 | 2014 | 1034 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2016 | 1098 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2832 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2011 | 1126 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2017 | 4569 | 0.020 |
Why?
| | Cell Movement | 1 | 2010 | 965 | 0.010 |
Why?
| | Brain | 1 | 2017 | 2941 | 0.010 |
Why?
| | Macrophages | 1 | 2010 | 1511 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2013 | 3869 | 0.010 |
Why?
|
|
Martin Carli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|